CVS Health price target lowered to $58 from $68 at RBC Capital
RBC Capital analyst Ben Hendrix lowered the firm’s price target on CVS Health (CVS) to $58 from $68 and keeps an Outperform rating on the ...
Analyst Expectations For CVS Health's Future
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $68.4, with a high ...
CVS is closing hundreds of stores by the end of the year
Rite-Aid filed for bankruptcy in July and closed nearly 74 stores this year. Walgreens CEO Tim Wentworth also announced ...
Veterans Day 2024 store hours: What stores are open and closed on Monday? Walmart, Target, CVS, Kohl’s and more
Here is a list of many popular retailers that are confirmed to be open on Veterans Day 2024, along with their store hours, ...
CVS Health: Buy Rating with Projected EPS Growth and Strategic Optimism Amid Retail Challenges
Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target was ...
CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Taking into account the latest results, the current consensus from CVS Health's 23 analysts is for revenues of US$385.9b in ...
Nasdaq25d
CVS Health price target lowered to $66 from $73 at Mizuho
Mizuho lowered the firm’s price target on CVS Health (CVS) to $66 from $73 and keeps an Outperform rating on the shares. The firm cut estimates following last week’s preannouncement.